Hematocrit correlates with blood pressure in young male office workers

Industrial Health

Volumn 37, Issue 1, 1999, Pages 76-81

  Nishikido, Noriko ^a   Kobayashi, Toshio ^b   Kashiwazaki, Hiroshi ^c  

^a ST LUKE'S INTERNATIONAL UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Blood pressure; Cardiovascular risk factors; Hematocrit; Hypertension; Young office workers

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; DIASTOLIC BLOOD PRESSURE; HEMATOCRIT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OFFICE WORKER; REGRESSION ANALYSIS; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

EID: 0033061964     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.37.76     Document Type: Article

References (29)

1. McDonough JR, Hames CG, Garrison GE, Stulb SC, Lichtman MA, Hefelfinger DC (1965) The relationship of hematocrit to cardiovascular states of health in the negro and white population of Evans county, Georgia. J Chron Dis 18, 243-57.
2. Tibblin G, Bergentz SE, Bjure J, Wilhelmsen L (1966) Hematocrit, plasma protein, plasma volume, and viscocity in early hypertensive disease. Am Heart J 72, 165-76.
3. Cirillo M, Laurenzi M, Trevisan M, Stamler J (1992) Hematocrit, blood pressure, and hypertension. The Gubbio population study. Hypertension 20, 319-26.
4. Sorlie PD, Garcia-Palmieri MR, Costas R, Havlik RJ (1981) Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program. Am Heart J 101, 456-61.
5. Carter C, McGee D, Reed D, Yano K, Stemmermann G (1983) Hematocrit and the risk of coronary heart disease: The Honolulu Heart Program. Am Heart J 105, 674-9.
6. Goubali A, Voukiklaris G, Kritsikis Sp, Viliotou F, Stamatis D (1995) Relation of hematocrit values to coronary heart disease, arterial hypertension, and respiratory impairment in occupational and population groups of the athens area. Angiology 46, 719-25.
7. Knottnerus JA, Swaen GM, Slangen JJ, Volovics A, Durinck J (1988) Haematologic parameters as risk factors for cardiac infarction, in an occupational health care setting. J Clin Epidemiol 41, 67-74.
8. Yoshino T, Momonoya I, Hattori M, Kagamimori S (1993) A case report with special reference to correlation between increased hematocrit and angina on effort. Jpn J Ind Health 35, 44-5 (In Japanese).
9. Lowe GDO, Robertson J, Dunn FG, Lorimer AR, Forbes CD (1985) Haematocrit in patients attending a hypertension clinic. Scott Med J 30, 168-72.
10. Zannad F, Voisin P, Brunotte F, Bruntz JF, Stoltz JF, Gilgenkrantz JM (1988) Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy. J Hypertens 6, 293-7.
11. Elwood PC, Mahler R, Sweetnam P, Moore F (1970) Association between circulating haemoglobin level, serum cholesterol, and blood pressure. Lancet i, 589-91.
12. Koenig W, Sund M, Ernst E, Keil U, Rosenthal J, Hombach V (1991) Association between plasma viscosity and blood pressure. Results from the MONICA-Project Augsburg. Am J Hypertens 4, 529-36.
13. Paul O, Leper MH, Phelan WH (1963) A longitudinal study of coronary heart disease. Circulation 28, 20-31.
14. Shurtleff D (1970) Some characteristics related to the incidence of cardiovascular disease and death. Framingham study, 16-year follow-up. In: The Framingham study-an epidemiological investigation of cardiovascular disease. eds by Kannel WB, Gordon T. U.S. Govt. Printing Office, Washington, D.C.
15. Abu-Zeid HAH, Chapman JM (1976) The relation between hemoglobin level and the risk for ischemic heart disease. A prospective study. J Chronic Dis 29, 395-403.
16. Schnall PL, Pieper C, Schwartz JE, Karasek RA, Schlussel Y, Devereux RB, Ganau A, Alderman M, Warren K, Pickering TG (1990) The relationship between 'job strain', workplace diastolic blood pressure, and left ventricular mass index. Results of case-control study. JAMA 263, 1929-35.
17. Schnall PL, Schwartz JE, Landsbergis PA, Warren K, Pickering TG (1992) Relation between job strain, alcohol, and ambulatory blood pressure. Hypertension 19, 488-94.
18. Winkleby MA, Ragland DR, Syme L (1988) Self-reported stressors and hypertension: evidence of an inverse association. Am J Epidemiol 127, 124-34.
19. Tarumi K, Hagihara A, Morimoto K (1993) An inquiry into the relationship between job strain and blood pressure in male white-collar workers. Jpn J Ind Health 35, 269-76.
20. Hayashi T, Kobayashi Y, Yamaoka K, Yano E (1996) Effect of overtime work on 24-hour ambulatory blood pressure. J Occup Environ Med 38, 1007-11.
21. Reed DM, LaCroix AZ, Karasek RA, Miller D, MacLean CA (1989) Occupational strain and the incidence of coronary heart disease. Am J Epidemiol 129, 495-502.
22. Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH (1990) Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81, 107-17.
23. Ruddel H, Langewitz W, Neus H, Schiebener A, Schmieder R, Schulte W (1982) Cardiovascular reactivity during mental stress testing, the type A interview, and exercise testing in healthy male subjects. Act Nerv Super Suppl 3, 268-73.
24. Tarazi RC, Frohlich ED, Dustan HP (1968) Plasma volume in men with essential hypertension. N Engl J Med 278, 762-5.
25. Dustan HP, Tarazi RC, Bravo EL, Dart RA (1973) Plasma and extra-cellular fluid volumes in hypertension. Suppl I to Circulation Res 32 and 33, 173-81.
26. Emery AC, Whitcomb WH, Frohlich ED (1974) "Stress" polycythemia and hypertension. JAMA 229, 159-62.
27. Chrysant SG, Frohlich ED, Adamopoulos PN (1976) Pathophysiologic significance of "Stress" or relative polycythemia in essential hypertension. Am J Cardiol 37, 1069-72.
28. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and phase II clinical trial. N Engl J Med 316, 73-8.
29. Raine AEG (1988) Hypertension, blood viscosity, and cardiovascular morbidity in renal failure. Implications of erythropoietin therapy. Lancet 1, 97-100.